Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Gastroesophageal cancer

Gastroesophageal cancer

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Gastroesophageal cancer

12 trials tracked for Gastroesophageal cancer.

12Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 10 Phase 1 2
  1. Phase 2 Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer Completed
  2. Phase 2 Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer Completed
  3. Phase 2 Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma Completed
  4. Phase 2 Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer. Completed
  5. Phase 2 FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer Completed
  6. Phase 2 APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers Completed
Show 6 more trials
  1. Phase 2 Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach Completed
  2. Phase 2 A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies Completed
  3. Phase 2 An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients Completed
  4. Phase 2 A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer Completed
  5. Phase 1 TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma Completed
  6. Phase 1 A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers Completed

Showing the 12 most-cited and recently-updated of 12 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Sintilimab Combined With Chemotherapy Improves Outcomes in Advanced Gastroesophageal Cancer
Oncology Meta-analysis
Sintilimab Combined With Chemotherapy Improves Outcomes in Advanced Gastroesophageal Cancer Immunotherapy combined with chemotherapy improves survival for gastroesophageal cancer
A meta-analysis of 6,625 patients shows that adding PD-1 inhibitors to chemotherapy significantly improves survival in advanced gastroesopha…
Combining immunotherapy with chemotherapy offers better survival outcomes for patients with advanced gastroesophageal cancer than chemothera…
Frontiers Sep 22, 2026